Reply to Marx et al
Clin Infect Dis
.
2017 Oct 15;65(8):1429-1430.
doi: 10.1093/cid/cix554.
Authors
Allan R Tunkel
1
,
Rodrigo Hasbun
2
,
Adarsh Bhimraj
3
,
Karin Byers
4
,
Sheldon L Kaplan
5
,
W Michael Scheld
6
,
Diederik van de Beek
7
,
Thomas P Bleck
8
,
Joseph R Zunt
9
Affiliations
1
Department of Internal Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
2
Department of Infectious Diseases, The University of Texas Health Sciences Center at Houston.
3
Department of Infectious Diseases, Cleveland Clinic, Ohio.
4
Division of Infectious Diseases, University of Pittsburgh Medical Center, Pennsylvania.
5
Department of Pediatrics, Section of Infectious Diseases, Baylor Medical College, Houston.
6
Division of Infectious Diseases, University of Virginia, Charlottesville.
7
Department of Neurology, University of Amsterdam, The Netherlands.
8
Departments of Neurological Sciences, Neurosurgery, Anesthesiology, and Medicine, Rush Medical College, Chicago, Illinois.
9
Departments of Neurology, Global Health, Medicine-Infectious Diseases, and Epidemiology, University of Washington, Seattle.
PMID:
28633345
PMCID:
PMC5850625
DOI:
10.1093/cid/cix554
No abstract available
Publication types
Letter
Comment
MeSH terms
Cerebral Ventriculitis*
Humans
Judgment
Meningitis*
Microbial Sensitivity Tests
Vancomycin
Substances
Vancomycin